Improved methods for electroacupuncture and electromyographic recordings in normal and parkinsonian rhesus monkeys

Journal of Neuroscience Methods

Volumn 192, Issue 2, 2010, Pages 199-206

  Zhao, Feng ^a,c   Fan, Xiaotong ^b,c   Grondin, Richard ^c   Edwards, Ramsey ^c   Forman, Eric ^c   Moorehead, Jennifer ^c   Gerhardt, Greg ^c   Wang, Xiaomin ^a   Zhang, Zhiming ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Acupuncture; Electroacupuncture; Electromyography; Parkinson; Rhesus monkeys; Rigidity

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; APOMORPHINE;

ACUPUNCTURE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELECTROACUPUNCTURE; ELECTROMYOGRAPHY; EXPERIMENTAL STUDY; FEMALE; LOCOMOTION; MUSCLE CONTRACTION; MUSCLE RIGIDITY; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALS; ELECTROACUPUNCTURE; ELECTROMYOGRAPHY; MACACA MULATTA; MPTP POISONING; VIDEO RECORDING;

EID: 77956760687     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2010.07.016     Document Type: Article

References (53)

1. Ai Y., Markesbery W., Zhang Z., Grondin R., Elseberry D., Gerhardt G.A., et al. Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects. J Comp Neurol 2003, 461(2):250-261.
2. Andersen A.H., Zhang Z., Zhang M., Gash D.M., Avison M.J. Age-associated changes in rhesus CNS composition identified by MRI. Brain Res 1999, 829(1-2):90-98.
3. Andersen A.H., Zhang Z., Barber T., Rayens W.S., Zhang J., Grondin R., et al. Functional MRI studies in awake rhesus monkeys: methodological and analytical strategies. J Neurosci Methods 2002, 118(2):141-152.
4. Boonstra T.A., Van der Kooij H., Munneke M., Bloem B.R. Gait disorders and balance disturbances in Parkinson's disease: clinical update and pathophysiology. Curr Opin Neurol 2008, 21(4):461-471.
5. Cameron J.L., Rockcastle N., Zigmond M.J., Leak R.K., Smith A., Lopresti B.J., et al. Exercise protects the striatum against MPTP damage in nonhuman primates. 2009 neuroscience meeting planner 2009, Society for Neuroscience, Chicago, IL, [program 430.7/13, online].
6. Cass W.A., Grondin R., Andersen A.H., Zhang Z., Hardy P.A., Hussey-Andersen L.K., et al. Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys. Neurobiol Aging 2007, 28(2):258-271.
7. Chen Q., Andersen A.H., Zhang Z., Ovadia A., Cass W.A., Gash D.M., et al. Functional MRI of basal ganglia responsiveness to levodopa in parkinsonian rhesus monkeys. Exp Neurol 1999, 158(1):63-75.
8. Cho S.H., Whang W.W. Acupuncture for alcohol dependence: a systematic review. Alcohol Clin Exp Res 2009, 33(8):1305-1313. [Epub 2009 Review April 30].
9. Cui C.L., Wu L.Z., Luo F. Acupuncture for the treatment of drug addiction. Neurochem Res 2008, 33(10):2013-2022. [Epub 2008 Review July 10].
10. Ding F., Luan L., Ai Y., Walton A., Gerhardt G.A., Gash D.M., et al. Development of a stable, early stage unilateral model of Parkinson's disease in middle-aged rhesus monkeys. Exp Neurol 2008, 212(2):431-439.
11. Endo T., Okuno R., Yokoe M., Akazawa K., Sakoda S. A novel method for systematic analysis of rigidity in Parkinson's disease. Mov Disord 2009, 24(15):2218-2224.
12. Eng M.L., Lyons K.E., Greene M.S., Pahwa R. Open-label trial regarding the use of acupuncture and yin tui na in Parkinson's disease outpatients: a pilot study on efficacy, tolerability, and quality of life. J Altern Complement Med 2006, 12(4):395-399.
13. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., et al. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 1996, 380(6571):252-255.
14. Gerhardt G.A., Cass W.A., Huettl P., Brock S., Zhang Z., Gash D.M. GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys. Brain Res 1999, 817(1-2):163-171.
15. Gerhardt G.A., Cass W.A., Yi A., Zhang Z., Gash D.M. Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys. J Neurochem 2002, 80(1):168-177.
16. Grondin R., Zhang Z., Yi A., Cass W.A., Maswood N., Andersen A.H., et al. Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain 2002, 125(Pt. 10):2191-2201.
17. Grondin R., Cass W.A., Zhang Z., Stanford J.A., Gash D.M., Gerhardt G.A. Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged rhesus monkeys. J Neurosci 2003, 23(5):1974-1980.
18. Grondin R., Zhang Z., Ai Y., Ding F., Walton A.A., Surgener S.P., et al. Intraputamenal infusion of exogenous neurturin protein restores motor and dopaminergic function in the globus pallidus of MPTP-lesioned rhesus monkeys. Cell Transplant 2008, 17(4):373-381.
19. Hardy P.A., Gash D., Yokel R., Andersen A., Ai Y., Zhang Z. Correlation of R2 with total iron concentration in the brains of rhesus monkeys. J Magn Reson Imaging 2005, 21(2):118-127.
20. Hogrel J.Y. Clinical applications of surface electromyography in neuromuscular disorders. Neurophysiol Clin 2005, 35(2-3):59-71. [Review].
21. Jia J., Sun Z., Li B., Pan Y., Wang H., Wang X., et al. Electro-acupuncture stimulation improves motor disorders in Parkinsonian rats. Behav Brain Res 2009, 205(1):214-218.
22. Lam Y.C., Kum W.F., Durairajan S.S., Lu J.H., Man S.C., Xu M., et al. Efficacy and safety of acupuncture for idiopathic Parkinson's disease: a systematic review. J Altern Complement Med 2008, 14(6):663-671.
23. Liang X.B., Liu X.Y., Li F.Q., Luo Y., Lu J., Zhang W.M., et al. Long-term high-frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia nigra and ventral tegmental area following medial forebrain bundle axotomy. Brain Res Mol Brain Res 2002, 108(1-2):51-59.
24. Liang X.B., Luo Y., Liu X.Y., Lu J., Li F.Q., Wang Q., et al. Electro-acupuncture improves behavior and upregulates GDNF mRNA in MFB transected rats. Neuroreport 2003, 14(8):1177-1181.
25. Luan L., Ding F., Ai Y., Andersen A., Hardy P., Forman E., et al. Pharmacological MRI (phMRI) monitoring of treatment in hemiparkinsonian rhesus monkeys. Cell Transplant 2008, 17(4):417-425.
26. Maswood N., Grondin R., Zhang Z., Stanford J.A., Surgener S.P., Gash D.M., et al. Effects of chronic intraputamenal infusion of glial cell line-derived neurotrophic factor (GDNF) in aged Rhesus monkeys. Neurobiol Aging 2002, 23(5):881-889.
27. Maswood N., Young J., Tilmont E., Zhang Z., Gash D.M., Gerhardt G.A., et al. Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease. Proc Natl Acad Sci USA 2004, 101(52):18171-18176.
28. Meigal A.I., Rissanen S., Tarvainen M.P., Karjalainen P.A., Iudina-Vassel I.A., Airaksinen O., et al. Novel parameters of surface EMG in patients with Parkinson's disease and healthy young and old controls. J Electromyogr Kinesiol 2009, 19((June) 3):e206-e213.
29. Mera T.O., Johnson M.D., Rothe D., Zhang J., Xu W., Ghosh D., et al. Objective quantification of arm rigidity in MPTP-treated primates. J Neurosci Methods 2009, 177(1):20-29.
30. Miyoshi Y., Zhang Z., Ovadia A., Lapchak P.A., Collins F., Hilt D., et al. Glial cell line-derived neurotrophic factor-levodopa interactions and reduction of side effects in parkinsonian monkeys. Ann Neurol 1997, 42(2):208-214.
31. Nguyen T.V., Brownell A.L., Iris Chen Y.C., Livni E., Coyle J.T., Rosen B.R., et al. Detection of the effects of dopamine receptor supersensitivity using pharmacological MRI and correlations with PET. Synapse 2000, 36(1):57-65.
32. NIH consensus development pane on acupuncture. JAMA 1998, 17(November):1518-1524.
33. Okuno R., Fujimoto S., Akazawa J., Yokoe M., Sakoda S., Akazawa K. Analysis of spatial temporal plantar pressure pattern during gait in Parkinson's disease. Conf Proc IEEE Eng Med Biol Soc 2008, 2008:1765-1768.
34. Ovadia A., Zhang Z., Gash D.M. Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys. Neurobiol Aging 1995, 16(6):931-937.
35. Poewe W. Clinical measures of progression in Parkinson's disease. Mov Disord 2009, 24(Suppl. 2):S671-S676. [Review].
36. Ramani R., Wardhan R. Understanding anesthesia through functional imaging. Curr Opin Anaesthesiol 2008, 21(5):530-536. [Review].
37. Robichaud J.A., Pfann K.D., Leurgans S., Vaillancourt D.E., Comella C.L., Corcos D.M. Variability of EMG patterns: a potential neurophysiological marker of Parkinson's disease. Clin Neurophysiol 2009, 120(2):390-397.
38. Samuels N., Gropp C., Singer S.R., Oberbaum M. Acupuncture for psychiatric illness: a literature review. Behav Med 2008, 34(2):55-64. [Review].
39. Schwarting R.K., Huston J.P. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog Neurobiol 1996, 50(2-3):275-331. [Review].
40. Shulman L.M., Wen X., Weiner W.J., Bateman D., Minagar A., Duncan R., et al. Acupuncture therapy for the symptoms of Parkinson's disease. Mov Disord 2002, 17(4):799-802.
41. Stacy M. Apomorphine: North American clinical experience. Neurology 2004, 62(6 Suppl. 4):S18-S21. [Review].
42. Walker F.O. Huntington's disease. Lancet 2007, 369(9557):218-228. [Review].
43. Wang S.M., Kain Z.N., White P. Acupuncture analgesia. I. The scientific basis. Anesth Analg 2008, 106(2):602-610. [Review].
44. Wang H., Qi H., Wang B.S., Cui Y.Y., Zhu L., Rong Z.X., et al. Is acupuncture beneficial in depression: a meta-analysis of 8 randomized controlled trials?. J Affect Disord 2008, 111(2-3):125-134. [Review].
45. Xia R., Sun J., Threlkeld A.J. Analysis of interactive effect of stretch reflex and shortening reaction on rigidity in Parkinson's disease. Clin Neurophysiol 2009, 120(7):1400-1407.
46. Xin T., Ai Y., Gerhardt G., Gash D., Zhang Z. Globus pallidus plays a critical role in neurotrophic factor induced functional improvements in hemiparkinsonian monkeys. Biochem Biophys Res Commun 2008, 370(3):434-439.
47. Zesiewicz T.A., Evatt M.L. Potential influences of complementary therapy on motor and non-motor complications in Parkinson's disease. CNS Drugs 2009, 23(10):817-835. [Review].
48. Zhang Z., Miyoshi Y., Lapchak P.A., Collins F., Hilt D., Lebel C., et al. Dose response to intraventricular glial cell line-derived neurotrophic factor administration in parkinsonian monkeys. J Pharmacol Exp Ther 1997, 282(3):1396-1401.
49. Zhang Z., Zhang M., Ai Y., Avison C., Gash D.M. MPTP-induced pallidal lesions in rhesus monkeys. Exp Neurol 1999, 155(1):140-149.
50. Zhang Z., Andersen A.H., Avison M.J., Gerhardt G.A., Gash D.M. Functional MRI of apomorphine activation of the basal ganglia in awake rhesus monkeys. Brain Res 2000, 852(2):290-296.
51. Zhang Z., Andersen A., Smith C., Grondin R., Gerhardt G., Gash D. Motor slowing and parkinsonian signs in aging rhesus monkeys mirror human aging. J Gerontol A Biol Sci Med Sci 2000, 55(10):B473-B480.
52. Zhang Z., Andersen A., Grondin R., Barber T., Avison R., Gerhardt G., et al. Pharmacological MRI mapping of age-associated changes in basal ganglia circuitry of awake rhesus monkeys. Neuroimage 2001, 14(5):1159-1167.
53. Zhang Z., Andersen A.H., Ai Y., Loveland A., Hardy P.A., Gerhardt G.A., et al. Assessing nigrostriatal dysfunctions by pharmacological MRI in parkinsonian rhesus macaques. Neuroimage 2006, 33(2):636-643.